Get started
Author

Rediet Fikru Gebresenbet

Observed name: Gebresenbet, Rediet Fikru
Institution: BioInvent (Sweden)
ORCID: 0000-0002-5057-3988
Observed ORCID: 0000-0002-5057-3988
OpenAlex ID: A5008815689
Injury severity level and associated factors among road traffic accident victims attending emergency department of Tirunesh Beijing Hospital, Addis Ababa, Ethiopia: A cross sectional hospital-based study
2019 · Rediet Fikru Gebresenbet, Anteneh Dirar Aliyu · PLoS ONE · 54
Micro-encapsulation differentially impacts probiotic effects on brain structure and function in an elderly population – A randomised placebo-controlled trial
2025 · Julia Rode, Ashley N. Hutchinson, et al. · Brain Behavior and Immunity · 15
Effectiveness and cost-effectiveness of community-based TB screening algorithms using computer-aided detection (CAD) technology alone compared with CAD combined with point-of-care C reactive protein testing in Lesotho and South Africa: protocol for a paired screen-positive trial
2025 · Aita Signorell, Alastair van Heerden, et al. · BMJ Open · 13
Active case detection using loop-mediated isothermal amplification technology and treatment versus standard of care for malaria in pregnancy in Ethiopia (LAMPREG): a pragmatic randomised diagnostic outcomes trial
2025 · Mekonnen Teferi, Banchamlak Tegegne, et al. · The Lancet Primary Care · 7
PDF
Active case detection and treatment of malaria in pregnancy using LAMP technology (LAMPREG): a pragmatic randomised diagnostic outcomes trial—study protocol
2022 · Rediet Fikru Gebresenbet, Claire Kamaliddin, et al. · BMJ Open · 6
PDF
Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trial
2026 · Klaus Reither, Fiona Vanobberghen, et al. · The Lancet Infectious Diseases · 3
Community-based tuberculosis screening using Computer-Aided Detection (CAD) technology alone compared with CAD combined with point-of-care C-reactive protein testing: a paired screen-positive trial
2026 · Reither, Klaus, Vanobberghen, Fiona, et al. · Zenodo (CERN European Organization for Nuclear Research)
Works count: 7
Citation count: 98
H-index: 5
I10-index: 3
Year
Topic
Type